Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China flag China · Delayed Price · Currency is CNY
5.68
+0.12 (2.16%)
May 8, 2026, 3:04 PM CST

SHE:002252 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,8821,4012,9834,0013,9782,747
Short-Term Investments
311.57705.31----
Trading Asset Securities
---197.41237.77219.38
Cash & Short-Term Investments
2,1942,1072,9834,1984,2162,966
Cash Growth
-45.67%-29.37%-28.95%-0.41%42.11%33.90%
Accounts Receivable
2,3892,2231,810774.08915.44649.52
Other Receivables
78.1792.813.319.812.021.21
Receivables
2,4672,3161,814783.88917.46650.73
Inventory
5,5515,3664,2933,6673,2693,173
Prepaid Expenses
-58.637.70.070.10.14
Other Current Assets
191.9103.93160.925.9271.4181.69
Total Current Assets
10,4039,9519,2578,6758,4736,872
Property, Plant & Equipment
2,6582,6621,9221,4531,2821,279
Long-Term Investments
15,08716,00416,77716,17715,70213,878
Goodwill
8,1998,1995,0735,0734,7034,900
Other Intangible Assets
731.27732.55485.01233.85175.49163.18
Long-Term Deferred Tax Assets
88.9593.5275.1489.8183.55104.27
Long-Term Deferred Charges
28.2629.7328.4721.2925.7828.97
Other Long-Term Assets
786.99108.7112.22205.341311.54
Total Assets
37,98337,78133,63131,92830,45827,237
Accounts Payable
621.36343.021,0761,6511,130956.29
Accrued Expenses
100.52362.09341.83289.17275.36234.64
Short-Term Debt
1,2801,309----
Current Portion of Long-Term Debt
117.02107.93----
Current Portion of Leases
-3.414.610.411.984.09
Current Income Taxes Payable
79.5945.3525.9494.5791.0353.53
Current Unearned Revenue
7.53.544.6922.6491.7628.69
Other Current Liabilities
585.32561.52198.18186.9734.5429.38
Total Current Liabilities
2,7922,7361,6522,2451,6251,307
Long-Term Debt
2,5472,473----
Long-Term Leases
9.5310.3912.991.491.854.16
Long-Term Unearned Revenue
21.1213.6110.969.4912.7715.2
Long-Term Deferred Tax Liabilities
43.2144.8914.8216.025.346.44
Other Long-Term Liabilities
46.946.9-7.06--
Total Liabilities
5,4595,3251,6912,2791,6451,332
Common Stock
6,6386,6386,6386,6456,7416,741
Additional Paid-In Capital
14,04414,04214,05813,80514,56014,560
Retained Earnings
12,43412,11810,8599,1107,5335,843
Treasury Stock
-522.95-522.95-77.18-182.92--
Comprehensive Income & Other
-69.02180.85448.62255.67-15.72-1,241
Total Common Equity
32,52432,45631,92629,63428,81925,902
Minority Interest
--14.4615.86-5.371.72
Shareholders' Equity
32,52432,45631,94129,65028,81325,904
Total Liabilities & Equity
37,98337,78133,63131,92830,45827,237
Total Debt
3,9543,90417.591.913.828.25
Net Cash (Debt)
-1,760-1,7982,9654,1964,2122,958
Net Cash Growth
---29.34%-0.36%42.38%34.00%
Net Cash Per Share
-0.27-0.270.450.640.620.44
Filing Date Shares Outstanding
6,5806,5576,6176,6056,7416,741
Total Common Shares Outstanding
6,5806,5576,6176,6056,7416,741
Working Capital
7,6127,2157,6066,4316,8495,566
Book Value Per Share
4.944.954.834.494.283.84
Tangible Book Value
23,59423,52426,36824,32723,94020,839
Tangible Book Value Per Share
3.593.593.993.683.553.09
Buildings
-2,1941,6611,3431,1951,146
Machinery
-1,5161,2871,2161,1321,074
Construction In Progress
-393.01289.21134.0374.1926.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.